Home/Filings/4/0000874716-25-000025
4//SEC Filing

Johnson Michael Perkins 4

Accession 0000874716-25-000025

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:43 PM ET

Size

18.5 KB

Accession

0000874716-25-000025

Insider Transaction Report

Form 4
Period: 2025-02-13
Johnson Michael Perkins
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-14+176406.342 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+179585.342 total
  • Tax Payment

    Common Stock

    2025-02-14$444.53/sh118$52,455467.342 total
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2025-02-13+3,6573,657 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (3,657 underlying)
  • Award

    Incentive Stock Option (right-to-buy)

    2025-02-13+217217 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (217 underlying)
  • Award

    Restricted Stock Unit

    2025-02-13+870870 total
    Common Stock (870 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14176352 total
    Common Stock (176 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14179535 total
    Common Stock (179 underlying)
Footnotes (6)
  • [F1]Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 31, 2024 and December 31, 2024.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
  • [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
  • [F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001917747

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:43 PM ET
Size
18.5 KB